Skip to main content
logo
Vicore Pharma Holding AB (publ) (VCRE)
NASDAQ: VCRE · Real-Time Price · USD
15.03
-1.02 (-6.76%)
Jul 7, 2026, 4:00 PM EDT - Market closed

Vicore Pharma Holding AB Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3.533.82109.35---
Revenue Growth (YoY)
-41.17%-96.51%----
Gross Profit
3.533.82109.35---
Selling, General & Admin
75.367.9150.4444.637.5321.61
Research & Development
414.22390.35249.26276.29249.97271.81
Operating Expenses
489.52458.26299.71320.89287.49293.42
Operating Income
-485.99-454.45-190.36-320.89-287.49-293.42
Interest Expense
--0.06-0.01-0-0.01-0.01
Interest & Investment Income
59.1323.8921.0810.540.910.65
Currency Exchange Gain (Loss)
-47.61-46.860.4-0.62-1.75-1.83
EBT Excluding Unusual Items
-474.47-477.47-168.89-310.97-288.34-294.61
Gain (Loss) on Sale of Investments
----0.36-0.47-2.12
Pretax Income
-474.47-477.47-168.89-311.33-288.81-296.74
Income Tax Expense
0.09--0.26-0.38-0.38-0.25
Net Income
-474.56-477.47-168.63-310.94-288.42-296.48
Net Income to Common
-474.56-477.47-168.63-310.94-288.42-296.48
Shares Outstanding (Basic)
252240137977270
Shares Outstanding (Diluted)
252240137977270
Shares Change (YoY)
50.17%75.30%41.72%33.71%3.64%28.44%
EPS (Basic)
-1.89-1.99-1.23-3.22-3.99-4.25
EPS (Diluted)
-1.89-1.99-1.23-3.22-3.99-4.25
Free Cash Flow
-407.27-375.74-164.95-249.58-299.92-265.17
Free Cash Flow Per Share
-1.62-1.57-1.21-2.58-4.15-3.81
Gross Margin
100.00%100.00%100.00%---
Operating Margin
-13779.08%-11905.82%-174.09%---
Profit Margin
-13454.92%-12509.14%-154.22%---
Free Cash Flow Margin
-11547.07%-9843.78%-150.85%---
EBITDA
--452.2-188.12-317.47-283.88-290.06
EBITDA Margin
---172.04%---
D&A For EBITDA
-2.242.243.423.613.36
EBIT
-485.99-454.45-190.36-320.89-287.49-293.42
EBIT Margin
---174.09%---